What’s new in diabetes
Amedication commonly prescribed for treating high blood pressure has been associated with lower fasting glucose levels in diabetics. University of Alabama at Birmingham researchers studied 5,000 adults with diabetes who are part of a larger national study in the U.S. examining reasons for geographic and racial differences in stroke risk. Among the diabetics in the subgroup who had type 1 or severe type 2 diabetes (all taking insulin alone or insulin with a calcium channel blocker medication), those who also took verapamil had much lower blood glucose levels than those who didn’t. The study’s authors think the results suggest that because verapamil seems to be most active in participants with type 1 diabetes or type 2 with strong beta cell damage, the drug may work on a structural level. A follow-up clinical trial is underway.